Transcripts

Revolution Medicines (RVMD) earnings call transcripts

Earnings call transcripts for Revolution Medicines, Inc., with a summary, the guidance given, and what analysts pressed on.

  • Q2 2026 earnings call

    Management framed 2026 as a pivotal year, pairing pancreatic launch preparation with broad RAS-inhibitor development while keeping treatment strategies open.

    Aug 05, 2026Confident0.78